Medpace Holdings, Inc.
MEDP
$592.01
-$9.37-1.56%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.10% | -0.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.10% | -0.26% | |||
| Cost of Revenue | 2.16% | 8.85% | |||
| Gross Profit | -0.70% | -3.41% | |||
| SG&A Expenses | 0.39% | 6.68% | |||
| Depreciation & Amortization | -2.84% | -3.16% | |||
| Other Operating Expenses | -2.84% | -2.80% | |||
| Total Operating Expenses | -0.81% | 1.79% | |||
| Operating Income | 3.76% | -7.68% | |||
| Income Before Tax | 2.76% | -5.89% | |||
| Income Tax Expenses | 27.74% | 9.31% | |||
| Earnings from Continuing Operations | -2.02% | -8.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.02% | -8.33% | |||
| EBIT | 3.76% | -7.68% | |||
| EBITDA | 3.45% | -7.48% | |||
| EPS Basic | -1.08% | -8.83% | |||
| Normalized Basic EPS | 3.75% | -6.40% | |||
| EPS Diluted | -0.70% | -8.21% | |||
| Normalized Diluted EPS | 4.23% | -5.89% | |||
| Average Basic Shares Outstanding | -0.95% | 0.54% | |||
| Average Diluted Shares Outstanding | -1.41% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||